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Objective: Accurate informal carer assessment of patient symptoms is likely to be valuable 
for decision making in managing the high symptom burden of COPD in the home setting. Few 
studies have investigated agreement between patients and carers in COPD. We aimed to assess 
agreement between patients and carers on symptoms, and factors associated with disagreement 
in a population-based sample of patients with advanced COPD.
Patients and methods: This was a prospective, cross-sectional analysis of data from 119 
advanced COPD patients and their carers. Patients and carers separately rated symptoms on a 
4-point scale. Wilcoxon signed-rank tests and weighted Cohen’s kappa determined differences in 
patient and carer scores and patient–carer agreement, respectively. We identified characteristics 
associated with incongruence using Spearman’s rank correlation and Mann–Whitney U tests.
Results: There were no significant differences between group-level patient and carer scores for 
any symptom. Patient–carer individual-level agreement was moderate for constipation (k=0.423), 
just below moderate for diarrhea (k=0.393) and fair for depression (k=0.341), fatigue (k=0.294), 
anxiety (k=0.289) and breathlessness (k=0.210). Estimation of greater patient symptom burden 
by carers relative to patients themselves was associated with non-spousal patient–carer relation-
ship, non-cohabitating patients and carers, carer symptoms of anxiety and depression and more 
carer unmet support needs. Greater symptom burden estimation by the patient relative to the 
carer was associated with younger patients and longer duration of COPD.
Conclusion: Overall, agreement between patients and carers was fair to moderate and was 
poorer for more subjective symptoms. There is a need to encourage open dialogue between 
patients and carers to promote shared understanding, help patients express themselves and 
encourage carers to draw attention to symptoms that patients do not report. The findings suggest 
a need to screen for and address both the psychological morbidities in patients with advanced 
COPD and their carers and unmet support needs in carers.
Keywords: COPD, informal carers, symptom, agreement
Plain language summary
Patients with COPD are affected by many symptoms such as breathlessness and tiredness in 
their day-to-day life. Family and friends (informal carers) often have to help manage these 
symptoms and decide when to get medical help. We wanted to find out whether patients and 
their carers agree in their judgments of the patient’s symptoms and what factors are associated 
with better or worse agreement as this may influence how well symptoms are managed, given 
the carer’s role in this. One hundred and nineteen patients and their carers separately rated how 
much the patient was bothered by six common symptoms in COPD. Agreement between patients 
and carers was worse for less obvious symptoms such as depression, fatigue, anxiety and breath-
lessness than constipation and diarrhea. Carers who said that their patient had more problematic 
symptoms than the patients themselves tended to have a non-spousal relationship with and live 
apart from their patient, be symptomatically anxious or depressed themselves and have more 
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unmet support needs. Patients reporting a greater symptom burden 
than their carer reported for them were younger and had COPD for 
longer. Our results suggest clinicians should seek opinions about 
symptoms from both the patient and their carer, promote shared 
understanding between patients and carers, and screen for mental 
health problems in both and unmet support needs in carers.
Introduction
COPD carries a high symptom burden, including psycho-
logical impacts such as anxiety and depression. Accurate 
symptom assessment by informal carers, typically family 
and friends, is likely to be important for their own deci-
sion making in supporting symptom management in the 
home setting and in deciding when to seek medical help.6,7 
Inaccurate assessment may negatively impact on the quality 
of the patient–carer relationship and the psychological health 
of both, and may lead to overtreatment or inadequate symp-
tom control.1,6,8–10
The extent of agreement between patients and carers is 
debated. There is widespread consensus in cancer that, at 
the group patient and carer cohort level, carers consistently 
overestimate patient symptoms,2–6,8,9,11–16 although the magni-
tude of the bias is small.2,11,13,17 At the individual patient–carer 
dyad level, strength of agreement on symptoms ranges from 
fair to substantial.2,4,11,12,14–19 It is well established in cancer 
populations that there is greater agreement between patients 
and carers for more observable symptoms (typically physical 
symptoms) compared to less observable symptoms (typically 
psychological symptoms).3–5,8,13,15 Group-level carer bias 
toward over-reporting is small for physical symptoms but 
moderate for psychological symptoms, with overestimation 
primarily for fatigue, pain, anxiety and depression.1,5,11,13 
Individual-level agreement is substantial on physical 
symptoms compared to only fair on psychological symp-
toms, with substantial agreement in nausea and vomiting, 
moderate agreement in pain, poor sleep, poor appetite and 
constipation, and poor to fair agreement in fatigue, anxiety 
and depression.2,3,11–13,15,18
Previous studies have investigated patient and carer char-
acteristics associated with symptom disagreement in cancer, 
with inconsistent links to carer age,3,9,10,12,18,20,21 sex,3,10,12,13,21 
patient–carer relationship3–5,11,20 and cohabitation,22 moder-
ate disease severity,1,21 poor patient and carer psychological 
health,1,13,20,23,24 greater subjective caring burden,1,3,8–10,20,23 lack 
of carer support and low carer self-esteem.3,12
Agreement between patients and carers has been exten-
sively investigated in cancer (including lung cancer),6,12 
but few studies have examined this in COPD19 or in 
population-based samples. We assessed agreement on how 
bothered the patient was by symptoms of breathlessness, 
fatigue, constipation, diarrhea, anxiety and depression. 
We took a holistic approach in considering the experience 
of those living with advanced COPD; thus, we included a 
spectrum of physical and psychological symptoms resulting 
from the condition, side effects of treatments, symptoms of 
conditions commonly comorbid with advanced COPD and 
symptoms which are difficult to manage in advanced COPD 
as the action of managing them leads to breathlessness, 
for example, walking to and using the toilet. We aimed to 
determine agreement between patients and carers on these 
symptoms, and factors associated with disagreement in a 
population-based sample of patients with advanced COPD.
Patients and methods
study design and participants
We conducted a cross-sectional analysis of data from patients 
and carers participating in baseline interviews for the Longi-
tudinal Interview Study component of the prospective Liv-
ing with Breathlessness Study.25 Primary care patients with 
well-characterized advanced COPD were recruited, if they 
met at least two of six inclusion criteria: forced expiratory 
volume in 1 second 30% predicted, at least two exacerba-
tions requiring prednisolone or antibiotics in the previous 
year, at least one hospital admission for COPD in the previ-
ous 2 years, long-term oxygen therapy, cor pulmonale and 
Medical Research Council Dyspnea scale 4+. Patients were 
excluded if they had a serious mental health problem, seri-
ous learning difficulty, active cancer or active alcoholism. 
Patients were asked to identify their primary informal carer 
(defined as the person who provided the most help and sup-
port and was not a health care professional) and these carers 
were also invited to participate. Carer exclusion criteria were 
as follows: under 18 years of age and unable to give informed 
consent. Care provided by carers could encompass personal 
care, for example, walking, dressing, washing, toileting 
as well as help with practical tasks, including shopping, 
cooking, housework, transport and paperwork. Six hundred 
and fifty-two patients with advanced COPD were identified 
by 63 primary care practices in the East of England (tar-
geted to maximize variability and representativeness), and 
were mailed a recruitment pack. Two hundred and thirty-five 
patients consented and participated (36% participation rate), 
from whom 117 carers were recruited to the study (50% 
participation rate; not all patients identified a carer). The 
study received ethics approval from the National Research 
Ethics Service Committee East of England – Cambridge 
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South (reference number 12/EE/0163). All participants gave 
written informed consent.
Data collection
Data were collected by conducting separate face-to-face 
interviews with the patients and carers. Sociodemographics 
of participants and measures of patients’ disease severity 
(% predicted forced expiratory volume in 1 second, Medical 
Research Council dyspnea scale, COPD Assessment Test 
score, number of hospital admissions, number of exacerba-
tions at home, long-term oxygen use) were obtained.26,27 
Psychological morbidity was identified for both patients 
and carers using the 14-item (two 7-item subscales) Hospital 
Anxiety and Depression Scale (HADS), with caseness for 
anxiety and depression defined as HADS-A and HADS-D 
score 11 (on a scale of 0–21).28 HADS was used as it is a 
well-validated and reliable self-report screening tool encom-
passing symptoms of both anxiety and depression, and has 
been shown to have reliability, convergent/discriminant 
validity and responsiveness to change in the primary care 
population.29 Carers identified unmet support needs on the 
14-item Carer Support Needs Assessment Tool (CSNAT). 
CSNAT covers 14 broad support domains in two groupings: 
support to enable the carer to provide care for the patient 
(these “enabling” domains include understanding the illness, 
knowing what to expect in the future, knowing who to con-
tact if concerned, talking with the patient about the illness, 
managing symptoms, providing personal care, equipment to 
help care) and support for carers’ own health and well-being 
(these “direct” domains include looking after own physi-
cal health, dealing with feelings and worries, support with 
beliefs or spiritual concerns, support with financial, legal and 
work issues, practical help at home, having time to oneself 
in the day, having a break from caring overnight). The need 
for more support is rated on a 4-point scale from 0 (none) 
to 3 (very much more). There is an “anything else” section 
enabling the carer to write in any other support need they 
may have that is not covered by the other 14 items.30 The 
CSNAT tool has been validated in a multicenter UK cohort 
of carers of palliative patients, demonstrating good face, 
content and criterion validity, and is being used in popula-
tions in Australia, USA, Canada, Europe and China.31 The 
CSNAT was used as it is the only validated screening tool 
which directly measures carers’ support needs (as opposed 
to the multiple tools that measure carer burden or distress, 
which are only indirect indicators of need). Patients and car-
ers rated patient symptoms of breathlessness, fatigue, consti-
pation, diarrhea, anxiety and depression (patients and carers 
were asked: “how much were you/was the patient bothered 
by the symptom in the past week”) on 4-point scales: 1 (not 
at all), 2 (a little), 3 (quite a bit) and 4 (very much).32
statistical analysis
Wilcoxon signed-rank test was used to determine whether 
differences between patient and carer scores were significant 
at the group level. The direction and magnitude of mean 
differences (mean scores of carers minus patients) were 
standardized to Cohen’s d effect size (statistical magnitudes 
of the observed bias), which were interpreted as 0.2= small, 
0.5= moderate and 0.8= large.33 Agreement on symptoms 
between patients and carers on the individual level was 
evaluated by weighted Cohen’s kappa, with 0.81–0.99 
defined as excellent agreement, 0.61–0.80 as substantial 
agreement, 0.41–0.60 as moderate agreement, 0.21–0.40 as 
fair agreement and 0.20 as poor agreement.34 Spearman’s 
correlation coefficients were used to identify the strength of 
association between difference in symptom burden estimates 
by patients and carers (carer score minus patient score) and 
variables of interest; positive correlation represents greater 
carer estimation relative to the patient as the variable of inter-
est increases. Mann–Whitney U tests identified categorical 
variables significantly associated with difference between 
patient and carer scores. Where variables were significant in 
univariate analysis, ordinal logistic regression was performed 
to determine significance when adjusted for patient and carer 
age and sex. Statistical significance was set at p0.05. All 
statistical analyses were carried out in SPSS Version 23 (IBM 
Corp., Armonk, NY, USA).
Results
Mean patient and carer age was 71.39±8.69 and 64.16±14.50 
years, respectively. Also, 62.4% of patients and 27.4% of 
carers were male; 80.9% of patients and carers were spouses 
and 87.2% lived together. Patient and carer characteristics 
are shown in Table 1.
Mean group-level differences and individual dyad-level 
agreement between patient and carer scores for all symptoms 
are shown in Table 2.
The most bothersome symptoms were breathlessness and 
fatigue, followed by anxiety and depression. There was no 
significant difference between mean patient and carer scores 
for any symptom at the group level. Agreement between 
patients and carers on symptoms at the individual dyad 
level was moderate for constipation, just below moderate 
for diarrhea and fair for depression, fatigue, anxiety and 
breathlessness.
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Factors associated with disparity in dyad-level patient 
and carer scores are shown in Table 3.
Carers being more likely to estimate greater symptom 
burden in patients relative to patients themselves was 
associated with non-spousal patient–carer relationships, 
non-cohabitation of patients and carers, carer caseness for 
anxiety and depression on HADS and unmet support needs in 
more CSNAT domains, specifically more direct carer support 
domains. Greater symptom burden estimation by the patient 
relative to the carer was associated with younger patients 
and longer self-reported duration of COPD. However, the 
strength of correlation between patient–carer disparity and 
carer unmet support needs, age and duration of COPD was 
weak. In multivariate analysis (Table 4), the association 
between unmet support needs in more direct carer support 
domains and greater estimation of breathlessness by carers 
remained when adjusted for patient and carer age and sex 
(odds ratio 1.250, 95% CI 1.031–1.516), as did younger 
patient age and greater patient estimation of depression (odds 
ratio 1.090, 95% CI 1.018–1.167).
Discussion
Unlike previous studies in cancer which have found a bias 
toward carer overestimation, there was no significant differ-
ence in this population-based sample of carers and patients 
with advanced COPD between their ratings of any symptom 
at the group level. However, agreement between patients and 
carers at the individual dyad level did not exceed moderate 
for any symptom, indicating lack of agreement between 
patients and carers within individual dyads which are masked 
at the group (cohort) level. What is not known is whether the 
patient’s or the carer’s reporting reflects the “true” symptom 
experience, and previous studies have suggested that the 
patient’s view cannot be considered to be the gold standard. 
However, it could be that there is no “true” experience and 
that alternative viewpoints are valuable.35
There are several possible explanations for disagreement. 
First, it is known that patients engage in protective buffering, 
concealing symptoms in order to minimize the burden on 
their carer.12,21,24 Response shift may occur in patients, with 
those with advanced disease reporting less symptom burden 
possibly because patients who are living with advanced 
COPD simply accept and consciously do their best to mini-
mize their symptoms or subconsciously expect, and therefore 
experience, less symptom burden.36,37 Carers may find it less 
easy to accept symptoms, and their impacts, leading to esti-
mation of greater symptom burden by the carer. Conversely, 
limited carer presence at patient–clinician contacts may result 
in lower carer awareness of symptoms and, therefore, lower 
estimation of symptom burden. Interestingly, there was a 
tendency toward lower carer estimation for five of the six 
symptoms, possibly reflecting longer disease trajectories in 
COPD and slower disease progression, compared to previous 
Table 1 sociodemographic and clinical characteristics of patients 
and carers
Characteristics Patients Carers
sample size 117 117
age, years 71.39 (8.69) 64.16 (14.50)
sex, male, n (%) 73 (62.4) 32 (27.4)
Marital status, n (%)
single 1 (0.9) 7 (6.1)
Partner 99 (85.3) 97 (85.1)
separated/divorced/widowed 16 (13.8) 10 (8.8)
living alone, n (%) 12 (10.3) 3 (2.7)
educational level, n (%)
none 54 (47.8) 53 (47.3)
a level/O level 18 (15.9) 17 (15.2)
higher 18 (15.9) 19 (17.0)
Others 23 (20.4) 23 (20.5)
Occupation, n (%)
higher managerial/professional 6 (5.2) 4 (3.5)
lower managerial/professional 10 (8.6) 7 (6.2)
non-manual 40 (34.5) 57 (50.4)
skilled manual 5 (4.3) 11 (9.7)
semi-skilled manual 35 (30.2) 13 (11.5)
Unskilled 20 (17.2) 21 (18.6)
Income, n (%)
£220/week 20 (19.0) 17 (17.0)
£221–£350/week 42 (40.0) 39 (39.0)
£351–£505/week 19 (18.1) 19 (19.0)
£506–£732/week 13 (12.4) 15 (15.0)
£733/week 11 (10.5) 10 (10.0)
Patient–carer relationship, n (%)
spouse 93 (80.9)
Child 14 (12.1)
Other 8 (7.0)
Patient–carer cohabitation, n (%) 102 (87.2)
smoking, n (%)
Current 20 (17.2)
Former 93 (80.2)
never 3 (2.6)
Duration of COPD, years 11.36 (10.49)
% predicted FeV1 38.23 (20.41)
MrC dyspnea scale score 3.64 (1.06)
CaT score 23.43 (7.16)
no of hospital admissions 0.53 (0.86)
no of exacerbations at home 2.94 (3.46)
long-term oxygen therapy, n (%) 22 (20.2)
Duration of caring, years 11.34 (13.52)
hours of care, n (%)
19 h/week 42 (39.3)
20–49 h/week 29 (27.1)
50 h/week 36 (33.6)
Patient comorbidities 3.91 (2.00)
Carer comorbidities 1.47 (1.48)
Note: all variables are expressed as mean (sD) unless otherwise stated.
Abbreviations: CaT, COPD assessment test; FeV1, forced expiratory volume in 
1 second; MrC, Medical research Council.
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Table 2 Mean group-level differences and individual dyad-level agreement between patient and carer symptom ratings
Symptoms Sample 
size
Patient 
mean 
score (SD)
Carer 
mean 
score (SD)
Absolute mean 
difference (SD)
Standardized 
mean 
difference
Wilcoxon 
signed-rank 
test p-valuea
Weighted 
Cohen’s kappa 
(95% CI)b
Breathlessness 106 3.25 (0.68) 3.10 (0.85) −0.151 (0.934) −0.162 0.089 0.210 (0.053–0.367)
Fatigue 105 2.90 (0.99) 2.84 (0.91) −0.067 (1.103) −0.061 0.571 0.294 (0.161–0.427)
anxiety 96 2.22 (1.08) 2.20 (1.05) −0.021 (1.196) −0.018 0.749 0.289 (0.137–0.440)
Depression 100 1.90 (1.06) 1.81 (0.94) −0.090 (1.055) −0.085 0.342 0.341 (0.195–0.486)
Constipation 91 1.60 (0.93) 1.58 (0.96) −0.022 (0.954) −0.023 0.840 0.423 (0.246–0.599)
Diarrhea 93 1.31 (0.59) 1.40 (0.75) 0.086 (0.702) 0.123 0.264 0.393 (0.231–0.555)
Notes: aMean group-level difference. bIndividual dyad-level agreement.
Table 3 Factors associated with disparity between individual dyad-level patient and carer symptom ratings
Factors Breathlessness Fatigue Constipation Diarrhea Anxiety Depression
Patient age, ρ (p-value) 0.009 (0.930) 0.073 (0.457) 0.050 (0.635) 0.086 (0.414) −0.003 (0.977) 0.218 (0.029)*
Carer age, ρ (p-value) −0.042 (0.672) 0.046 (0.646) 0.022 (0.836) −0.100 (0.344) −0.086 (0.412) −0.143 (0.164)
Patient sex, mean differencea
Male −0.227 −0.123 0.034 0.000 −0.068 −0.097
Female −0.025 0.025 −0.125 0.250 0.054 −0.079
p-value 0.304 0.630 0.600 0.224 0.770 0.908
Carer sex, mean differencea
Male −0.100 −0.035 −0.269 0.231 −0.179 −0.172
Female −0.171 −0.079 0.077 0.030 0.044 −0.056
p-value 0.800 0.752 0.266 0.557 0.462 0.595
Patient–carer relationship, mean differencea
spouse −0.151 −0.105 −0.066 0.104 −0.143 −0.198
non-spouse −0.150 0.105 0.200 0.000 0.474 0.368
p-value 0.900 0.610 0.666 0.692 0.048* 0.043*
Patient–carer cohabitation, mean differencea
Yes −0.151 −0.152 −0.085 0.108 −0.167 −0.193
no −0.154 0.539 0.556 −0.100 1.000 0.667
p-value 0.653 0.063 0.150 0.478 0.002* 0.007*
Duration of COPD, ρ (p-value) −0.052 (0.602) −0.207 (0.035)* −0.017 (0.870) 0.064 (0.542) 0.059 (0.570) −0.107 (0.292)
% predicted FeV1, ρ (p-value) −0.013 (0.934) −0.078 (0.605) 0.029 (0.860) 0.050 (0.760) 0.013 (0.936) 0.134 (0.386)
Patient haDs-a caseness, mean differencea
Yes −0.226 −0.267 0.148 0.000 −0.226 −0.258
no −0.110 −0.028 −0.129 0.129 0.065 −0.015
p-value 0.700 0.450 0.259 0.187 0.350 0.221
Patient haDs-D caseness, mean differencea
Yes −0.412 0.059 0.357 −0.071 0.000 −0.188
no −0.092 −0.129 −0.120 0.118 −0.039 −0.074
p-value 0.348 0.536 0.165 0.343 0.749 0.621
Carer haDs-a caseness, mean differencea
Yes −0.069 0.000 0.208 0.039 0.520 0.400
no −0.160 −0.093 −0.121 0.106 −0.229 −0.260
p-value 0.473 0.484 0.089 0.867 0.012* 0.017*
Carer haDs-D caseness, mean differencea
Yes −0.250 0.000 0.222 0.100 −0.200 0.800
no −0.120 −0.076 −0.062 0.085 −0.012 −0.193
p-value 0.671 0.866 0.636 0.859 0.668 0.008*
no. of CsnaT domains, ρ (p-value) 0.246 (0.016)* 0.053 (0.610) −0.152 (0.171) 0.179 (0.101) 0.220 (0.039)* 0.187 (0.075)
no. of direct CsnaT domains, ρ (p-value) 0.209 (0.035)* 0.054 (0.588) −0.085 (0.430) 0.135 (0.205) 0.213 (0.041)* 0.167 (0.103)
no. of enabling CsnaT domains, ρ (p-value) 0.186 (0.066) 0.030 (0.771) −0.194 (0.075) 0.195 (0.070) 0.165 (0.120) 0.134 (0.199)
Notes: aMann–Whitney U test was used for these variables. spearman’s correlation was used for all other variables. *p0.05.
Abbreviations: CsnaT, Carer support needs assessment Tool; FeV1, forced expiratory volume in 1 second; haDs, hospital anxiety and Depression scale.
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studies in cancer, leading to carer compassion-fatigue and 
response shift.
We found higher agreement for more observable physical 
symptoms such as constipation and diarrhea than less observ-
able psychological symptoms such as anxiety and depression 
and those with emotional valence such as fatigue and breath-
lessness. This can be attributed to greater difficulty appraising 
psychological symptoms due to a lack of overt and non-verbal 
cues and, therefore, the need for greater interpretation of cues, 
which carers may not have the knowledge or skills to do,3,5,12 
but which could be gained. It may also be easier for patients 
to conceal psychological symptoms, and carers may be more 
prone in these circumstances to make assessments colored 
by their individual frame of reference.6,12,24 In addition, 
constipation and diarrhea were less-frequent and episodic 
symptoms, which may have increased carers’ awareness of 
them as a notable change in contrast to the more daily-present 
symptoms such as breathlessness and fatigue.
Estimation of greater patient symptoms of anxiety and 
depression by carers was seen in non-spousal and non-
cohabitating patient–carer dyads, probably because these 
carers have less face-to-face contact with their patients,5,22 
so have less opportunity to observe particularly subjective 
symptoms. Carer anxiety and depression caseness on the 
HADS scale were also associated with estimation of greater 
patient symptoms of anxiety and depression by carers, prob-
ably due to projection of their own experiences and feelings, 
thus creating a more negative view of the situation.1,12 Higher 
carer rating of breathlessness was associated with unmet 
carer support needs across a wider range of carer support 
domains (number of CSNAT domains) and interestingly 
only across more domains of direct support for carer health 
and well-being rather than support to enable the carer to 
provide care for the patient, which persisted when adjusted 
for patient and carer age and sex; this may suggest that carer 
perception of the patient’s breathlessness is related to the 
carer’s own physical, psychological and spiritual well-being, 
more than difficulties in managing it.38 Estimation of greater 
depressive symptoms by relatively younger patients found in 
univariate and multivariate analyses may reflect the greater 
difficulty of psychologically adjusting to disease limitations 
at an earlier stage in life, although given that the cohort was, 
in general, relatively old (reflecting being population based 
with advanced COPD), even those who were “younger” may 
not be “young” in the broader COPD population.
These findings have implications for clinical practice 
and research. Given the only moderate agreement between 
patients and carers, clinicians and researchers should, in the T
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context of COPD, seek the perceptions of both.35 Clinicians 
may be well placed to open a dialogue between patients and 
carers within dyads,8 helping them to gain a shared under-
standing of each other’s position and address any differences 
in perceptions. One approach that has been found to be of 
benefit is perspective taking, which involves imagining the 
patient’s perspective rather than assuming their feelings (the 
cognitive, rather than the affective, dimension of empathy).39 
In addition, we need to find ways of helping patients express 
themselves and ensure that we respond to their needs without 
forcing them to acknowledge or experience their illness more 
than they want to. Carers can have a role in this, helping to 
draw attention to symptoms that patients do not emphasize 
and considering whether patients need help in being a little 
more demanding about some of their needs. To help promote 
agreement, screening for and addressing psychological 
morbidities in both patients and carers and unmet support 
needs in carers is required. However, patient assessment for 
anxiety and depression is itself not widespread in respira-
tory clinics (or indeed for any chronic disease and among all 
health professionals), so it may be challenging to implement 
carer assessment of these in a clinical setting. Finally, further 
investigation of the impact of patient–carer disagreement is 
warranted.
Limitations
One of the limitations of the study is that the cohort was 
limited to patients with advanced COPD and, therefore, may 
not represent the majority of those with COPD. Nevertheless, 
disease severity was not found in this study to be associated 
with agreement between patients and carers, so it is possible 
that similar patient–carer agreement relationships may be 
found in general COPD populations. Additionally, data were 
not available for other symptoms associated with COPD, 
such as cough. We used the HADS screening tool to identify 
caseness for anxiety and depression in patients and carers, 
which is not a formal diagnosis of anxiety or depression, 
but the stringent definition of caseness of HADS score 11 
(moderate to severe depression) may have improved accu-
racy. Finally, the cross-sectional analysis could establish 
association, but not causality.
Conclusion
Agreement between patients and carers was fair to moder-
ate and was poorer for less-observable symptoms. Greater 
symptom burden estimation by the carer was associated 
with less patient–carer contact, carer symptoms of anxiety 
and depression and a wider range of unmet carer support 
needs; greater estimation by the patient was associated with 
being younger and having COPD for longer. There is a need 
to encourage open dialogue between patients and carers 
to promote shared understanding of patients’ symptom 
burden. This may encourage carers to explore the impact 
of symptoms that patients do not emphasize. Screening 
for and addressing psychological morbidities in patients 
with advanced COPD and their carers, and identifying and 
responding to unmet support needs in carers may identify 
opportunities for supportive intervention. There is a poten-
tial to develop a useful therapeutic dialogue addressing 
the complimentary viewpoints of patients and carers, and 
clinicians.
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